Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong · Delayed Price · Currency is HKD 24.16
+0.52 (2.20%)
Sep 10, 2025, 1:45 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 58.30 billion as of September 9, 2025. Its market cap has increased by 60.00% in one year.
Market Cap
58.30B
Enterprise Value
62.50B
Revenue
14.37B
Ranking
n/a
PE Ratio
38.51
Stock Price
24.16
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 58.30B, an increase of 592.24%. That is a compound annual growth rate of 33.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 58.27B | 30.84% |
| Dec 31, 2024 | 44.53B | -14.67% |
| Dec 29, 2023 | 52.19B | -40.01% |
| Dec 30, 2022 | 86.99B | -33.39% |
| Dec 31, 2021 | 130.60B | 16.63% |
| Dec 31, 2020 | 111.98B | 155.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 297.05B |
| Hansoh Pharmaceutical Group Company | 231.38B |
| JD Health International | 201.85B |
| Innovent Biologics | 172.13B |
| Sino Biopharmaceutical | 161.14B |
| WuXi Biologics | 158.17B |
| Akeso | 131.26B |
| CSPC Pharmaceutical Group | 131.25B |